NCT05207618View on ClinicalTrials.gov

Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 21, 2021

Primary Completion Date

February 20, 2022

Study Completion Date

April 20, 2022

Conditions

Irritable Bowel SyndromeDiarrhea

Interventions

DIETARY_SUPPLEMENT

ARBOX (QUEBRACHO AND CHESNUT EXTRACT)

ARBOX TWICE A DAY FOR 60 days

Trial Locations (1)

B1622

Hospital de Clinicas Jose de San Martin. Buenos Aires University, Buenos Aires

All Listed Sponsors

collaborator

SILVATEAM

UNKNOWN

lead

Hospital de Clinicas José de San Martín

OTHER

NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant | Biotech Hunter | Biotech Hunter